FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...